Its an issue that, ADR tried to obviscate the situation rather than answer the question. ADR had no answer and need Hotcopper folks to "google it" to get data ADR should have to share to investors. ADR are not tracking this, you dont develop and approve a product overnight. ADR without this data may not realise that if there are a couple of key generics it could mean losing patients when they move from hospital to community management, which may be a reason for a practise not to adopt the products due to lack of consistant patient coverage. ADR risk being caught out through the lack of information most companies would see as being the basics of undersatnding their market.
Having said that if you have next to no share of a huge market then short trem its not going to be a problem now, what is a bigger iss is as you scale up you risk missing a key strategic roadbloack due to lack of understandind or being complacent.
ADR Price at posting:
0.3¢ Sentiment: None Disclosure: Held
